European Journal of Heart Failure 2002 4(5):667; doi:10.1016/S1388-9842(02)00180-0
© 2002 European Society of Cardiology
Corrigendum to Torasemide in chronic heart failure: results of the TORIC study [Eur. J. Heart Fail. 4 (2002) 507–513]
a Cardiocirculatory Research Unit, Research Center, University Hospital La Fe Valencia, Spain
b Division of Cardiovascular Pathophysiology School of Medicine and Department of Cardiology and Cardiovascular Surgery, University Clinic, University of Navarra Pamplona, Spain
* Corresponding author. Tel.: +34-948-42-56-00; fax: +34-948-42-56-49. E-mail address: jadimar{at}unav.es
The author regrets that there was an error in the above article. The relevant text and figure are now given correctly, below.
Section 3.2 should read: A significantly lower incidence of cardiac mortality was reported in the torasemide group (n=11, 1.4%) compared to the furosemide/other diuretic group (n=21, 3.5%) (p<0.05), representing a 59.7% decrease in the risk of cardiac mortality (Fig. 1).
|
| Notes |
|---|
|
|
|---|
PII of the original article: S1388-9842(02)00122-8.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
